Zobrazeno 1 - 10
of 140
pro vyhledávání: '"Raymond M. Quock"'
Autor:
Abigail L. Brewer, Christina C. Lewis, Liudmyla Eggerman, Alexis Blokker, John A. Burkland, Megan Johnsen, Raymond M. Quock
Publikováno v:
Behavioural Pharmacology. 34:112-122
Publikováno v:
Pain Management Nursing. 23:616-624
Pain, drug cravings, and opioid withdrawal symptoms can interfere with substance use disorder or opioid tapering treatment goals.This pilot study investigated the feasibility of a protocol designed to test opioid withdrawal symptom relief relative to
Autor:
Zhihua Jiang, Amy L. Zinski, Raymond M. Quock, Maria A. Gartstein, Jennifer J. Michal, Shane Carrion, Jon F. Davis
Publikováno v:
International Journal of Biological Sciences
Because of their relatively short lifespan (
Autor:
Marian Wilson, Tamara Odom-Maryon, Karen Stanek, Trevor Roush, Joseph Muriungi, Alvina Jesse, Raymond M. Quock, Matthew Layton
Publikováno v:
Journal of addictions nursing. 33(1)
Opioid withdrawal symptoms can interfere with substance use disorder treatment goals. This study investigated the acceptability, feasibility, and treatment effects of hyperbaric oxygen therapy (HBOT) as an adjunct to reduce withdrawal symptoms for ad
Publikováno v:
Behavioural Pharmacology. 31:61-72
Chemotherapeutic agents can cause peripheral neuropathy, a deleterious side effect of cancer treatment. Hyperbaric oxygen (HBO2) treatment has shown great potential for decreasing pain in numerous clinical pain conditions and in preclinical studies.
Publikováno v:
Brain Research. 1699:107-116
New pain treatments are in demand due to the pervasive nature of pain conditions. Hyperbaric oxygen (HBO(2)) has shown potential in treating pain in both clinical and preclinical settings, although the mechanism of this effect is still unknown. The a
Autor:
Raymond M. Quock, Matthew E. Layton, Devon A Hansen, Hans P. A. Van Dongen, Lillian Skeiky, Marian Wilson
Publikováno v:
Sleep. 44:A305-A305
Introduction Individuals with opioid use disorder (OUD) report significant sleep/wake disturbance, which continues even after stabilization on medication-assisted treatment (MAT). However, the nature of sleep/wake disturbance in this population has n
Autor:
Matthew E. Layton, J A Erwin, D Reynolds, A Little-Gott, Marian Wilson, H Van Dongen, Raymond M. Quock, Myles Finlay, Devon A Hansen
Publikováno v:
Sleep. 43:A394-A395
Introduction It has been established that the use of opioids suppresses stage N3 sleep. For individuals with opioid use disorder (OUD), medication-assisted treatment (MAT) is a widely employed opioid replacement therapy used to mitigate withdrawal ef
Autor:
Raymond M. Quock, Abigail L. Brewer
Publikováno v:
The FASEB Journal. 33
Publikováno v:
Brain Research Bulletin. 125:218-221
Nitrous oxide (N2O)-induced antinociception in mice is dependent on the neuromodulator nitric oxide (NO). In contrast to C57BL/6J (B6) mice, DBA/2J (D2) mice fail to respond to N2O with a robust antinociceptive response or with an increase in brain n